Zhang et al. [17] reported a PRRT2 heterozygous mutation in a three generations Chinese family with ICCA and PKD and found oxcarbazepine/phenytoin treatment was dramatically effective for them. The gene discussed is PRRT2; the disease is infantile convulsions and choreoathetosis.